1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INMED PHARMACEUTICALS INC
InMed Pharmaceuticals Inc
XNAS: INM
Download real time
1.66 0.98 (144.12%)
79.20% Fall from 52W High
81.9M
XNAS Volume
High volume+gain today

XNAS 19 May, 2026 2:12 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for InMed Pharma Inc

The latest disclosure was made by Eric A. Adams in InMed Pharma Inc where a trade of 35,000 Employee Stock Option (Right to Buy) done was reported to US exchanges on Dec. 19, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eric A. Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 35,000 49,050 - - Employee Stock Option (Right to Buy)
Neil A. Klompas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,750 5,250 - - Employee Stock Option (Right to Buy)
Andrew Hull Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,750 2,711 - - Employee Stock Option (Right to Buy)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 13,000 18,280 - - Employee Stock Option (Right to Buy)
Michael Woudenberg Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 18,000 25,445 - - Employee Stock Option (Right to Buy)
Shane Aaron Johnson Sr VP & General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 8,500 12,400 - - Employee Stock Option (Right to Buy)
Nicole Lemerond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,750 2,725 - - Employee Stock Option (Right to Buy)
N. Netta Jagpal Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 18,000 24,250 - - Employee Stock Option (Right to Buy)
John Steven Bathery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2025 1,750 5,250 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO 15 Dec 2025 250 14,050 - - Employee Stock Option (Expiration)
Andrew Hull Director 15 Dec 2025 14 961 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 15 Dec 2025 70 5,280 - - Employee Stock Option (Expiration)
Michael Woudenberg Chief Operating Officer 15 Dec 2025 60 7,445 - - Employee Stock Option (Expiration)
Neil A. Klompas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2025 3,500 3,500 - - Employee Stock Option (Right to Buy)
Andrew Hull Director 11 Jan 2025 2 975 - - Employee Stock Option (Expiration)
Johnson Aaron Shane Sr VP & General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 1,500 3,900 - - Employee Stock Option (Right to Buy)
Lemerond Nicole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 550 975 - - Employee Stock Option (Right to Buy)
Hull Andrew Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 550 977 - - Employee Stock Option (Right to Buy)
A. Eric Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 6,250 14,300 - - Employee Stock Option (Right to Buy)
T. Bryan Baldasare Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 550 975 - - Employee Stock Option (Right to Buy)
Jagpal N. Netta Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 3,750 6,250 - - Employee Stock Option (Right to Buy)
Hsu Eric C. Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 2,750 5,350 - - Employee Stock Option (Right to Buy)
Woudenberg Michael Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 3,750 7,505 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Consultant Sale of securities on an exchange or to another person at price $ 0.18 per share. 31 Jul 2024 240 0 - 0.2 42 Common Stock
Eric A. Adams Director, President & CEO 27 May 2024 1,139 161,000 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 27 May 2024 545 52,000 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 27 May 2024 485 52,000 - - Employee Stock Option (Expiration)
Michael Woudenberg Chief Operating Officer 27 May 2024 394 75,100 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 04 Mar 2024 309 52,545 - - Employee Stock Option (Expiration)
Andrew Hull Director Purchase of securities on an exchange or from another person at price $ 0.39 per share. 21 Feb 2024 37,500 38,258 - 0.4 14,625 Common Stock
Eric A. Adams Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.36 per share. 20 Feb 2024 41,600 43,959 - 0.4 14,922 Common Stock
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 21 Jan 2024 121 52,485 - - Employee Stock Option (Expiration)
Andrew Hull Director 14 Jan 2024 42 8,542 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 45,000 52,606 - - Employee Stock Option (Right to Buy)
A. Eric Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 136,000 162,139 - - Employee Stock Option (Right to Buy)
Lemerond Nicole Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 7,100 8,500 - - Employee Stock Option (Right to Buy)
Michael Woudenberg Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 65,000 75,494 - - Employee Stock Option (Right to Buy)
Aaron Shane Johnson Sr VP & General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 40,000 48,000 - - Employee Stock Option (Right to Buy)
Baldasare T. Bryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 7,100 8,500 - - Employee Stock Option (Right to Buy)
Tegge Jonathan Interim CFO 23 Dec 2023 30,000 31,400 - - Employee Stock Option (Right to Buy)
Andrew Hull Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 7,100 8,584 - - Employee Stock Option (Right to Buy)
Hsu C. Eric Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2023 45,000 52,854 - - Employee Stock Option (Right to Buy)
Woudenberg Michael Chief Operating Officer 05 Dec 2023 848 10,494 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 31 Aug 2023 327 7,854 - - Employee Stock Option (Expiration)
Eric A. Adams Director, President & CEO 16 May 2023 1,818 26,139 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 16 May 2023 152 8,181 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 16 May 2023 485 7,606 - - Employee Stock Option (Expiration)
Eric A. Adams Director, President & CEO 08 Mar 2023 545 27,957 - - Employee Stock Option (Expiration)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev 08 Mar 2023 545 8,333 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 08 Mar 2023 61 8,091 - - Employee Stock Option (Expiration)
Eric A. Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 15,000 28,502 - - Employee Stock Option (Right to Buy)
Andrew Hull Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 840 1,484 - - Employee Stock Option (Right to Buy)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 4,200 8,878 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 4,200 8,152 - - Employee Stock Option (Right to Buy)
Jonathan Tegge Interim CFO 16 Dec 2022 1,400 1,400 - - Employee Stock Option (Right to Buy)
Michael Woudenberg Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 7,500 11,342 - - Employee Stock Option (Right to Buy)
Bryan T. Baldasare Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 840 1,400 - - Employee Stock Option (Right to Buy)
Shane Aaron Johnson Sr VP & General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 4,200 8,000 - - Employee Stock Option (Right to Buy)
Nicole Lemerond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 840 1,400 - - Employee Stock Option (Right to Buy)
Sarah Li VP Accounting & Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2022 3,600 4,002 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 15,000 28,502 - - Employee Stock Option (Right to Buy)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 4,200 8,878 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 4,200 8,152 - - Employee Stock Option (Right to Buy)
Michael Woudenberg Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 7,500 11,342 - - Employee Stock Option (Right to Buy)
Shane Aaron Johnson Sr. VP & General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 4,200 8,000 - - Employee Stock Option (Right to Buy)
Nicole Lemerond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 14,000 14,000 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO 02 Jun 2022 13,636 337,576 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 02 Jun 2022 1,515 98,787 - - Employee Stock Option (Expiration)
Bryan T. Baldasare Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 14,000 14,000 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.89 per share. 14 Apr 2022 14,160 59,003 - 0.9 12,659 Common Stock
Eric A. Adams Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.85 per share. 13 Apr 2022 8,560 44,843 - 0.9 7,276 Common Stock
Michael Woudenberg See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2022 5,000 96,060 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 20 Feb 2022 3,030 100,302 - - Employee Stock Option (Expiration)
William J. Garner Director 24 Jan 2022 24,242 16,122 - - Employee Stock Option (Expiration)
Bruce S. Colwill CFO Purchase of securities on an exchange or from another person at price $ 1.09 per share. 24 Jan 2022 5,000 11,515 - 1.1 5,439 Common Stock
Eric A. Adams Director, President & CEO 24 Jan 2022 60,606 411,818 - - Employee Stock Option (Expiration)
Eric A. Adams Director, President & CEO 24 Jan 2022 60,606 351,212 - - Employee Stock Option (Expiration)
Andrew Hull Director 24 Jan 2022 30,303 16,122 - - Employee Stock Option (Expiration)
Adam D. Cutler Director 24 Jan 2022 22,727 16,122 - - Employee Stock Option (Expiration)
Adam D. Cutler Director 24 Jan 2022 1,515 38,849 - - Employee Stock Option (Expiration)
Adam D. Cutler Director 24 Jan 2022 6,061 40,364 - - Employee Stock Option (Expiration)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs 24 Jan 2022 12,121 103,332 - - Employee Stock Option (Expiration)
Shane Aaron Johnson SVP, GM of BayMedica LLC Purchase of securities on an exchange or from another person at price $ 1.26 per share. 06 Jan 2022 8,500 304,595 - 1.3 10,710 Common Stock
Shane Aaron Johnson SVP, GM of BayMedica LLC Purchase of securities on an exchange or from another person at price $ 1.33 per share. 30 Dec 2021 8,093 296,095 - 1.3 10,736 Common Stock
William J. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2021 7,000 40,364 - - Employee Stock Option (Right to Buy)
Catherine A. Sazdanoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2021 7,000 29,091 - - Employee Stock Option (Right to Buy)
Andrew Hull Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2021 7,000 46,425 - - Employee Stock Option (Right to Buy)
Adam D. Cutler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2021 7,000 46,425 - - Employee Stock Option (Right to Buy)
Shane Aaron Johnson SVP, GM of BayMedica LLC Purchase of securities on an exchange or from another person at price $ 1.37 per share. 15 Nov 2021 5,000 288,002 - 1.4 6,845 Common Stock
Bruce S. Colwill CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 60,000 150,303 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 125,000 472,424 - - Employee Stock Option (Right to Buy)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 35,000 116,969 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 35,000 115,453 - - Employee Stock Option (Right to Buy)
Michael Woudenberg VP, Chem/Manufacturing/Control Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2021 30,000 91,060 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.73 per share. 29 Sep 2021 8,800 36,283 - 1.7 15,224 Common Stock
Bruce S. Colwill CFO Purchase of securities on an exchange or from another person at price $ 1.77 per share. 28 Sep 2021 5,000 6,515 - 1.8 8,840 Common Stock
Eric A. Adams Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.75 per share. 28 Sep 2021 11,400 27,483 - 1.8 19,984 Common Stock
William J. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 7,000 7,000 - - Employee Stock Option (Right to Buy)
Bruce S. Colwill CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 60,000 60,000 - - Employee Stock Option (Right to Buy)
Catherine A. Sazdanoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 11,000 11,000 - - Employee Stock Option (Right to Buy)
Catherine A. Sazdanoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 7,000 7,000 - - Employee Stock Option (Right to Buy)
Eric A. Adams Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 125,000 125,000 - - Employee Stock Option (Right to Buy)
Andrew Hull Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 7,000 7,000 - - Employee Stock Option (Right to Buy)
Adam D. Cutler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 7,000 7,000 - - Employee Stock Option (Right to Buy)
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 35,000 35,000 - - Employee Stock Option (Right to Buy)
Alexandra D.J. Mancini Sr VP, Clinical Reg Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 35,000 35,000 - - Employee Stock Option (Right to Buy)
Michael Woudenberg VP, Chem/Manufacturing/Control Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2020 30,000 30,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters